Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Akoya Biosciences Inc
(NQ:
AKYA
)
2.910
+0.070 (+2.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Akoya Biosciences Inc
< Previous
1
2
3
4
5
Next >
Analyst Ratings for Akoya Biosciences
December 14, 2023
Via
Benzinga
Expert Ratings for Akoya Biosciences
November 13, 2023
Via
Benzinga
Recap: Akoya Biosciences Q3 Earnings
November 08, 2023
Via
Benzinga
Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
November 08, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Participate at Three Upcoming Investor Conferences
November 02, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023
October 31, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Where Akoya Biosciences Stands With Analysts
October 16, 2023
Via
Benzinga
Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures
October 17, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023
October 11, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms
September 19, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
August 07, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies
August 07, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya to Participate at Three Upcoming Investor Conferences
July 26, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner'
July 20, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Tripadvisor, Inc. (NASDAQ: TRIP) is not good enough, and he prefers Booking Holdings Inc. (NASDAQ: BKNG).
Via
Benzinga
Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023
July 12, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Virgin Galactic, Squarespace And Other Big Stocks Moving Higher In Friday's Pre-Market Session
June 16, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 14, 2023
Via
Benzinga
NextDecade, GigaCloud Technology And Other Big Stocks Moving Higher On Wednesday
June 14, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 14, 2023
Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 13, 2023
Via
Benzinga
Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 13, 2023
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 143% to $2.77 after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic...
Via
Benzinga
Why Shares of Akoya Biosciences Jumped on Tuesday
June 13, 2023
A rash of insider buying buoyed investor confidence in the medical instrument company.
Via
The Motley Fool
Akoya to Participate at Two Upcoming Investor Conferences
June 12, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
June 08, 2023
During Thursday, 35 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 08, 2023
Via
Benzinga
Akoya Biosciences Announces Pricing of Public Offering of Common Stock
June 08, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
Akoya Biosciences Announces Public Offering of Common Stock
June 07, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 10, 2023
Via
Benzinga
Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
May 08, 2023
From
Akoya Biosciences, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.